Showing 1 - 5 results of 5 for search 'Rachid Baz', query time: 0.03s Refine Results
  1. 1
    Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma

    Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma by Rachid Baz MD, Roy Furman MD, PhD, Katherine Simondsen PharmD, BCOP, Christine Stone PhD, MBA

    Published 2020-06-01
    Get full text
    Article
  2. 2
    PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION

    PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION by Cesar Rodriguez Valdes, Katja Weisel, Rachid Baz, Akshanth Polepally, Jeremy A. Ross, Ziyi Jin, Kristin D’amico, Orlando F. Bueno, Leanne Lash Fleming, Peter Voorhees

    Published 2023-08-01
    Get full text
    Article
  3. 3
    S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS

    S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH... by Krina Patel, Paula Rodríguez-Otero, Salomon Manier, Rachid Baz, Marc S. Raab, Michele Cavo, Natalie Callander, Luciano Costa, Philippe Moreau, Scott Solomon, Christine Chen, Noopur Raje, Christof Scheid, Michel Delforge, Jeremy Larsen, Thomas Pabst, Kenshi Suzuki, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Sergio Giralt, Maria-Victoria Mateos

    Published 2023-08-01
    Get full text
    Article
  4. 4
    P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY

    P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS... by Salomon Manier, Paula Rodríguez-Otero, Maria-Victoria Mateos, Hermann Einsele, Nizar J Bahlis, Nikhil Munshi, Sikander Ailawadhi, Bertrand Arnulf, Ajay Nooka, Ravi Vij, Ingerid Weum Abrahamsen, Annemiek Broijl, Sundar Jagannath, Reuben Benjamin, Usama Gergis, Douglas W. Sborov, Shinsuke Iida, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Rachid Baz

    Published 2023-08-01
    Get full text
    Article
  5. 5
    PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

    PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY M... by Turab Mohammed, Moazzam Shahzad, Lauren Peres, Sushmita Khadka, Christelle Colinleitzinger, Abida Babu, William Doyle, Omar Castaneda Puglianini, Laura Oswald, Gabe De Avila, Ariel Grajales-Cruz, Brandon Blue, Jose Ochoa-Bayona, Eric Smith, Salvatore Corallo, Farhad Khimani4, Rawan Faramand, Hany Elmariah, Aleksandr Lazaryan, Michael Jain, Hien Liu, Taiga Nishihori, Ken Shain, Rachid Baz, Melissa Alsina, Frederick Locke, Ciara Freeman, Doris Hansen

    Published 2023-08-01
    Get full text
    Article

Search Tools: